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Abstract
Matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) mass spectrometry (MS)
has been recently used to identify disease markers
by directly profiling and quantifying the pep-
tide/proteins in biological samples under differ-
ent physiological or experimental conditions. The
information of reproducibility of such quantitative
profiling method has not been available. It is
important to evaluate and reduce error from tech-
nical variation. In this study, an unbiased signal
acquisition strategy was used to evaluate the
effects of three sample-matrix spotting methods
and two matrix chemicals, -cyano-4-hydroxycin-
namic acid (CHCA) and sinapinic acid, on the
reproducibility of the peptide/protein signal
intensities. The sandwich spotting method using
0.1% nitrocellulose coating film and CHCA gave
the best quantitative results for the standard pep-
tides and proteins with mass <66.5 kDa. The nor-
malized signal intensities of the standard peptides
and proteins were directly proportional to their
concentrations with intra-assay (within-day) co-
efficient of variations (CVs) ranging from 6.5% to
17%. When analyzing serum peptides <6000 m/z,
the interassay (between-days) CVs of all the eval-
uated peptide peaks were <15%. These data indi-
cate that with the right MS analysis conditions,
MALDI-TOF MS appears to be a feasible tool for
directly profiling and quantifying the peptide/
proteins in biological samples.
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Introduction
Quantitative proteomics is concerned with
the identification of biological and physiolog-
ical changes in protein expression patterns
between biological samples under different
physiological, pathological, or experimental
conditions. Two-dimensional polyacrylamide
gel electrophoresis (2D PAGE) is the most
commonly used technology to separate indi-
vidual proteins, followed by image analysis to
obtain the quantity of individual protein spots.
Subsequently, the protein identity of a spot of
interest can be obtained by peptide mass finger-
printing with the use of matrix-assisted laser
desorption/ionization time-of-flight (MALDI-
TOF) mass spectrometry (MS) (1).
Recently, there has been increasing interest
in using gel-free approaches, such as surface-
enhanced laser desorption/ionization (SELDI)-
TOF ProteinChip technology (2–4) and direct
application of MALDI-TOF MS (5–8), to profil-
ing and quantification of individual peptides/
proteins in biological samples. MALDI-TOF
MS was applied to direct profiling and imag-
ing of peptides and proteins from mammalian
cells and tissue sections (5,6). Liquid-phase
isoelectric focusing electrophoresis has been
used to reduce signal suppression effects in
the MALDI-TOF MS analysis of serum pro-
teins (7). This approach was used to identify
potential lung cancer markers by comparing
the serum peptide/protein profiles between
lung cancer patients and individuals without
cancer (8).
MALDI-TOF MS has been being regarded
as a semiquantitative technology, and the
quantitative aspects have not been well exam-
ined. It has been shown that when a mixture
of very pure peptides/proteins is analyzed,
the relative ion yields of different peptide and
protein molecules can vary significantly from
preparation to preparation (9). As quantitative
proteomics identifies disease markers by mea-
suring relative differences between biological
samples under different physiological or ex-
perimental conditions, it is important to
evaluate the signal linearity and error caused
by technical variation and to increase the
precision.
In this study, using an unbiased automatic
mass spectrum acquisition protocol, we exam-
ined how different sample-matrix spotting
methods and matrix chemicals affect the
reproducibility of peptide/protein ion signals
when MALDI-TOF MS was used for direct
quantitative measurement of mixtures of pep-
tides and proteins. Finally, using serum as an
example, we attempted to apply our opti-
mized methodology in analyzing the peptide
profile of a complex peptide-protein mixture
and examined the interassay variation.
Materials and Methods
Nitrocellulose Preparation
A 2% (w/v, 20 g/L) nitrocellulose (NC)
solution was prepared by dissolving Hybond
C NC membrane (Amersham Biosciences,
Piscataway, NJ) in pure acetone and subse-
quently diluting it with same volume of iso-
propanol to form the 1% NC stock solution.
Different concentrations of NC solution (0.01%,
0.05%, 0.1%) were then prepared by diluting
with 1:1 (v/v) acetone-isopropanol solution.
Preparation of Matrix Chemical Solution
and Standard Peptide/Protein Mixture
An -cyano-4-hydroxycinnamic acid (CHCA;
Sigma, St. Louis, MO) matrix solution was
prepared by dissolving 1 mg of CHCA in 250
L of 50% acetonitrile (ACN) containing 0.3%
(v/v) trifluoroacetic acid (TFA). The saturated
solution was then diluted four times with 40%
ACN containing 0.1% TFA. A sinapinic acid
(SA; Fluka, St. Louis, MO) matrix solution
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(1 g/L) was prepared by dissolving SA in 30%
ACN and 0.2% TFA. Peptide and protein stan-
dards were prepared from the Sequazyme
peptide mass standard kit (Applied Biosys-
tems, Foster City, CA). Components of the
standard mixture are listed in Table 1.
Sample-Matrix Spotting Methods
The application of sample and matrix
chemical on a 100-shallow-well gold MALDI
sample stage (Applied Biosystems) was per-
formed on open bench at 24°C and approx
70% humidity. Three types of sample-matrix
spotting methods were used, as summarized
below:
Direct Mixing Method
One microliter of sample was mixed with
1 L of matrix chemical. Two microliters of the
sample-matrix mixture was then deposited
onto a shallow well (3.14 mm2) and air-dried.
Overlaying Method
One microliter of sample was directly spot-
ted onto a shallow well and air-dried. Then 1
L of matrix chemical was overlaid on the
sample afterward and air-dried.
NC Sandwich Method
One microliter of NC solution (0.01%,
0.05%, 0.1%, 0.25%, 0.5%, or 1.0%) was first
spotted onto a shallow well with a positive
displacement pipette and air-dried. Then 1 L
of matrix chemical was spotted and air-dried,
followed by addition of 1 L of sample and
air-drying. Finally, another 1 L of matrix
chemical was spotted over the sample and
air-dried.
Unbiased Automatic MALDI-TOF MS
Mass Spectrum Acquisition
All MALDI-TOF MS mass spectra were
acquired on a Voyager DE-PRO Biospectrom-
etry Workstation (Applied Biosystems) in pos-
itive linear mode using a nitrogen laser (337
nm). The acceleration voltage was 25 kV. The
low- (600–10,000 Dalton) and high- (10–200
kDa) molecular-weight proteins were detected
by different settings to achieve highest resolu-
tions. The laser power, grid voltage, and guide
wire voltage were optimized for different
sample-matrix spotting methods, different
matrix chemicals, and different mass ranges.
To overcome the problems of variations of
MS signals from different sample-matrix
cocrystals, we collected each sample mass
spectra automatically from 104 different posi-
tions on the sample-matrix spot in a spiral dis-
tribution pattern. For each position, MS data
were collected from 35 laser shots. The final
mass spectrum of a sample was the average of
the data (total of 3640 laser shots) from the
104 different positions. This automatic MS
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Table 1
Peptide and Protein Standards 
Used in the Present Study
Theoretical
Peptide/protein average Concentration 
standard mass, MH (pmol/L)
Des-Arg-
bradykinin 905.05 1.00
Angiotensin I 1297.51 3.30
Glu-fibrinopeptide B 1571.61 1.30
ACTH (clip 1–17) 2094.46 2.00
ACTH (clip 18–39) 2466.72 1.50
ACTH (clip 7–38) 3660.19 3.00
Insulin (bovine) 5734.59 4.50
Thioredoxin 





IgG (mouse) 148500.00 6.00
The concentrations that were used in the intra-assay
error experiments are listed. One microliter of the stan-
dard mixture was subjected to matrix-assisted laser
desorption/ionization time-of-flight mass spectrome-
try analysis. ACTH, adrenocorticotropic hormone.
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acquisition method aimed to avoid biased
selection of a “good” sample-matrix cocrystal
for mass spectrum collection, which might not
reflect accurately the peptide/protein content
of a sample.
Normalization of Peptide/Protein 
Signal Intensity
The raw spectra were processed with the
Voyager Data explorer software (version 4.0.0,
Applied Biosystems). The whole isotope
envelope was used to calculate the signal
intensity of a peptide/protein. After baseline
subtraction, the signal intensity of each pep-
tide/protein was normalized by presenting
either as a percentage of total peak area, or as
a relative peak intensity with the use of the
following equations.
Percentage of total peak area
Peak area of the interested peak
  100%
Sum of areas of all peaks
Relative peak intensity
Peak area of the interested peak
  100%
Peak area of an internal
reference peptide
Measurement of Signal Variations 
and Linearity
The peptide/protein standards and their
quantities (at low picomole levels) used in the
evaluation of intra-assay error are listed in
Table 1. For each combination of sample-
matrix spotting method and matrix chemical,
10 identical sample-matrix spots were pre-
pared and subjected to MS analysis indepen-
dently for the examination of intra-assay
(within-day) coefficient of variation (CV) for
each standard peptide/protein. For determi-
nation of interassay (between-days) CV, a con-
trol sample was analyzed in duplicate, and the
MS analysis was performed on five different
days for a total of five times. For assessing the
linearity of the peptide/protein signals, the
amount of a peptide/protein of interest was
varied while fixing the concentration of the
internal reference peptide.
Quantitative Profiling of Serum Peptides
One microliter of peptide standards at low
picomole levels (Table 1) were spiked into 20
L serum as an internal reference. The serum
was diluted and acidified with 60 L of
1% TFA solution. The mixture was then sub-
jected to ultrafiltration with a 30-kDa-cutoff
Microcon centrifugal filter device (Millipore,
Billerica, MA) according to the manufacturer’s
instructions. Two microliters of the filtrate was
analyzed with the use of the NC sandwich
method and CHCA matrix. The signals within
the range of 900–6000 m/z were collected with
the use of the unbiased automated acquisition
method. When examining the interassay vari-
ation, the control serum sample was processed
and applied onto the source plate on the day
of measurement.
Results
Effect of Sample-Matrix Spotting
Methods and Matrix Chemicals
on Reproducibility of
Peptide/Protein Signals
Because it is well established that CHCA
gives the highest sensitivity and resolution
in the detection of peptides, we only used
CHCA as the matrix chemical when quanti-
tatively profiling proteins <10 kDa (i.e.,
peptides) in the peptide/protein standard mix-
ture. The results are summarized in Table 2.
With the use of the unbiased automatic MS
acquisition protocol and the total peak area
normalization method, the direct mixing
sample-matrix spotting method (i.e., the con-
ventional dried-drop method) resulted in
intra-assay CV values from 10.5 to 27.5%.
Among all the tested sample-matrix spotting
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methods, the sandwich method with the use
of 0.1% NC provided the best reproducibility
of the peptide ion signals. The peak intensity
could be normalized with either the total
peak area or with the peak area of an internal
reference peptide. These two normalization
procedures resulted in intra-assay CVs in the
range of 6.5 to 17%.
For profiling proteins in the range of 10–150
kDa, the effects of the three sample-matrix
spotting methods and two matrix chemicals
were examined. The results are summarized
in Table 3. When only thioredoxin (11.67 kDa),
apomyoglobin (16.85 kDa), and bovine serum
albumin (BSA; 66.43 kDa) were considered,
the sandwich method with the use of 0.1% NC
and CHCA matrix was still a reliable method,
resulting in the low CV values for various pro-
teins. When the signal intensity was normal-
ized with an internal reference, the CV for of
measurement of BSA was only 8.5%.
When SA was used as the matrix chemical,
all of the proteins within the detectable range,
including mouse IgG, were ionized and de-
tected. However, in general, the results were
less reproducible (relatively higher CVs) when
compared with those obtained with the use of
CHCA. Because the sandwich method (0.1%
NC and CHCA) gave the best quantitative
results for profiling peptides/proteins of mass
<66,5 kDa, this approach was used and
referred to as NC-MALDI-TOF MS in the
following experiments.
Assay Linearity of the
Nitrocellulose-MALDI TOF MS 
for Peptides <6000 Dalton
The linearity of the NC-MALDI-TOF MS
method in quantitative profiling of a mixture
of peptides between 900 and 6000 Dalton was
examined. Adrenocorticotropic hormone (ACTH;
clip 18–39) or glu-fibrinopeptide B was used
as the internal reference peptide, and was
added to the samples at a fixed concentration.
Figure 1 shows typical mass spectra of the
quantitative analysis of the peptides when
using glu-fibrinopeptide B as the internal ref-
erence. Using glu-fibrinopeptide B (1571.61
m/z) as the internal reference peptide, the rel-
ative peak intensities of ACTH clip 1–17
(2094.46 m/z), ACTH clip 18–39 (2466.72
m/z), ACTH clip 7–38 (3660.19), and insulin
(5734.59 m/z) increased with their concentra-
tions (Fig. 2A–D). Using ACTH clip 18–39 as
the internal reference peptide, similar correla-
tions were observed when measuring the
intensities of des-arg-bradykinin (905.1 m/z)
and glu-fibrinopeptide B (Fig. 2E,F). Linear
equation was used in the curve fitting. All R2
values were ≥0.97. The results demonstrate
that the relative peak intensity is directly pro-
portional to the peptide concentration regard-
less of the mass of a peptide.
Accuracy of Mass Measurement
The accuracy and precision of the NC-
MALDI-TOF MS method in obtaining the pep-
tide mass values were examined. The results
are summarized in Table 4. For the assessed
mass range between 900 and 6000 Dalton, per-
centage errors for all of the tested standard
peptides were <0.05%. The CVs were all
<0.03%. These results suggest that introduc-
tion of a NC layer does not significantly affect
the mass accuracy of MALDI-TOF MS.
Application in Quantitative Profiling
of Serum Peptides
Serum samples from four individuals were
used to examine whether the NC-MALDI-TOF
MS method could be used in the quantitative
profiling of peptides in complex biological
samples. In the initial study, peptide standards
were first added to the serum as internal con-
trol, and the mixture was diluted fourfold and
acidified with 1% TFA. No detectable signal in
the peptide range was observed. To reduce the
complexity, we ultrafiltrated the fourfold
diluted and acidified samples with a 30-kDa-
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weight proteins before MS analysis. After
removing the proteins >30 kDa, peptide
peaks were observed in the mass spectra of
the serum samples (Fig. 3). One of the serum
samples was used to examine the interassay
errors. The interassay errors of 18 repre-
sentative peptide peaks (sample A) were
examined and are summarized in Table 5. 
All of the interassay CVs were between 3.5
and 15%.
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Fig. 1.Typical mass spectra of the quantitative analysis of the peptides when using glu-fibrinopeptide B as the
internal reference. When the concentration of the internal reference peptide glu-fibrinopeptide B was kept
constant, the relative intensities of angiotensin I, adrenocorticotropic hormone (ACTH; clip 1–17), and ACTH
(clip 18–39) increased with their concentrations.
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Discussion
Understanding the precision and linearity
is crucial to all quantitative studies, including
quantitative proteomic experiments. In exper-
iments aiming to identify significant differ-
ences between two sample groups, the
statistical power depends on the CVs of the
quantitative measurements. For assays with
higher CVs, a larger sample size is needed to
achieve the same degree of statistical power
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(10). In this study, we have demonstrated that
different sample-matrix spotting methods and
matrix chemicals do affect the reproducibility
of the intensity of peptide/protein ion signals.
The quantitative capability of MALDI-TOF
MS can be easily improved with the use of a
thin film of NC coating for sample-matrix
cocrystallization. The normalized signal inten-
sities of the peptides/proteins were directly
proportional to their concentrations with
Fig. 2.The relative intensities of the tested peptides were plotted against their concentrations.Assayed peptides:
(A) adrenocorticotropic hormone (ACTH; clip 1–17; 2094.46 m/z); (B) ACTH (clip 18–39; 2466.72 m/z);
(C) ACTH (clip 7–38; 3660.19); (D) insulin (5734.59 m/z); (E) des-arg-bradykinin (905.05 m/z); and (F) glu-
fibrinopeptide B (1571.61). Internal reference peptide: (A–D) glu-fibrinopeptide B; (E,F) ACTH (clip 18–39).
Linear equation was used in the curve fitting. The error bars represent the standard errors of the mean
relative intensities.
intra-assay and interassay CVs <17%. The
reproducibility of the NC-MALDI-TOF MS
method is comparable to technical variations
(20–30% CV) of the 2D PAGE technique (11)
Clinical Proteomics ________________________________________________________________ Volume 1, 2004
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Fig. 3. Representative mass spectra of serum samples from four individuals with the peptide range of 900–6000
m/z.The peptide standard adrenocorticotropic hormone 1–17 clip (2094.46 m/z) was used as the internal ref-
erence.The interassay errors for sample A are listed in Table 5.
Table 4 
Summary of the Accuracy and Precision of Measurement of the Masses for the Peptide
Standards by the NC MALDI-TOF MS Method 
Mean of masses from 
Theoretical average five independent 
Peptide mass, MH+ assays, MH+ Percentage error CV (%)
Des-arg-bradykinin 905.05 904.68 0.041 0.025
Angiotensin I 1297.51 1297.18 0.025 0.024
Glu-fibrinopeptide B 1571.61 1571.35 0.017 0.026
ACTH (clip 1–17) 2094.46 2094.32 0.007 0.025
ACTH (clip 18–39) 2466.72 2466.68 0.002 0.025
ACTH (clip 7–38) 3660.19 3660.26 –0.002 0.025
Insulin 5734.59 5734.95 –0.006 0.025
The masses shown were obtained from five independent assays. NC, nitrocellulose; MALDI-TOF MS, matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry analysis; CV, coefficient of variations;
ACTH, adrenocorticotropic hormone.
and those (CVs <15%) of SELDI ProteinChip
technology (12).
NC was first used by Preston et al. in
sample preparation for MALDI-TOF MS (13).
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denser network and provides more crystalliza-
tion cores for the formation of a layer of
homogeneous small sample-matrix cocrystals,
resulting in more homogeneous relative pep-
tide ion signals. NC concentrations of 0.01–3%
were tested in initial experiments. We found
that low NC concentrations (0.01 and 0.05%)
were ineffective in the formation of a layer of
homogenous NC film (data not shown). When
the NC concentration was too high (>1%), the
signal intensities of the peptide/protein peaks
fall significantly (data not shown). It is possible
that peptides/proteins are adsorbed to the NC
fiber by physicochemical forces such as
hydrophobic interactions, hydrogen bonding,
and electrostatic interactions when too much
NC is coated on the MALDI sample stage.
It is important to emphasize that in this
study we have only evaluated the effect of
matrix formulation and application on the
reproducibility of MALDI-TOF MS in quanti-
tative proteomic profiling. In future studies,
other matrix factors, such as drying condi-
tions, should be examined.
In conclusion, with the right MS analysis
conditions, MALDI-TOF MS appears to be a
feasible tool for directly profiling and quanti-
fying the peptides/proteins in biological sam-
ples with intra- and interassay CVs <17%.
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